Purchase Order 75N92025P00195

Award Date 6/5/25
Potential Completion Date 6/4/26
Potential Value $195K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis equipment. The $148,830.24 contract provides for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract, valued at $149,982.23, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services,...
This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The total ceiling value of the contract is $86,989.68. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing a range of goods and services to support genomic sequencing and analysis for research and diagnostics purposes. This includes various NextSeq, NovaSeq, MiSeq, and...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $59,936.42. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This delivery order is part of a larger...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
This firm fixed-price delivery order contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $149,937.55 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. This award is not associated with a set-aside...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $65,439.32, was awarded to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The contract is for the provision of Illumina sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq platforms, as well as accompanying reagents, consumables,...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $148,916.57 contract provides Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, and bioinformatics software and support for genomic analysis research at the NIH. Illumina has held prior prime contracts and subcontracts...

This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $195,464.40 contract provides for Illumina Sequencers Service Agreement, which includes the procurement of advanced sequencing instruments like NextSeq, NovaSeq, MiSeq, and iSeq systems, along with associated reagents, consumables, maintenance services, and technical support. This contract does not have a set-aside designation and is expected to be completed by June 4, 2026. Illumina also holds two Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs, valued at $231,165 and $1,297,062 respectively, which enable the flexible procurement of Illumina's sequencing platforms, reagents, and bioinformatics products across multiple VA facilities. Through these federal contract awards, Illumina supports critical research initiatives in areas such as infectious disease, cancer diagnostics, environmental monitoring, and agricultural genetic analysis across various government agencies.

Generated 5/20/25, 1:49 PM